5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilbao, R; Bustos, M; Duarte, M; Mazzolini, G; Melero, I; Narvaiza, I; Prieto, J; Qian, C; Tirapu, I | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Colonic Neoplasms
Article | Year |
---|---|
Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment.
Topics: Adenoviridae; Animals; Antibodies, Monoclonal; Cell Adhesion; Cell Movement; Cell Separation; Colonic Neoplasms; Endothelium; Female; Flow Cytometry; Galactosides; Immunohistochemistry; Indoles; Interleukin-12; Liver Neoplasms; Lymphocytes; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Neoplasm Metastasis; Receptors, Vitronectin; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Transgenes; Vascular Cell Adhesion Molecule-1 | 2001 |